Published Date: 31-Oct-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Cell Culture Protein Surface Coating Market size is expected to reach $1.9 billion by 2028, rising at a market growth of 15.5% CAGR during the forecast period.
The Self-coating market is generating high revenue in the Global Cell Culture Protein Surface Coating Market by Type in 2021; thereby, achieving a market value of $1.2 billion by 2028. Increasing expenditures on research & development are a major contributor to segment expansion. Focusing on the manufacture of monoclonal antibodies, protein therapies, induced pluripotent stem cell research, and cry banking, biotechnology and biopharmaceutical companies are increasingly adopting this approach in order to enhance their results.
The Human-derived market is exhibiting a CAGR of 15.8% during (2022 - 2028). The increasing growth of the segment is a result of the fact that human-derived protein materials are in high demand due to their extensive use in insulin synthesis. Instances of diabetes are surging all over the world, necessitating an increasing focus on novel drug discovery and better treatment.
The North America market dominated the Global Cell Culture Protein Surface Coating Market by Region in 2021; thereby, achieving a market value of $671.3 million by 2028. The Europe market is experiencing a CAGR of 15.1% during (2022 - 2028). Additionally, The Asia Pacific would witness a CAGR of 16.1% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Corning, Inc., Merck Millipore (Merck Group), Promega Corp., Sartorius Stedim Biotech S.A. (Sartorius AG), Greiner Bio-One International GmbH, PerkinElmer, Inc., BioVision, Inc., Bio-Techne Corporation and Viogene BioTek Corp.
By Protein Source
Unique Offerings from KBV Research